Metabolic Reprogramming of the Urea Cycle Pathway in Experimental Pulmonary Arterial Hypertension Rats Induced by Monocrotaline

Respiratory Research - United Kingdom
doi 10.1186/s12931-018-0800-5
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Maprotiline Prevents Monocrotaline-Induced Pulmonary Arterial Hypertension in Rats

Frontiers in Pharmacology
Pharmacology
2018English

Calorie Restriction Attenuates Monocrotaline-Induced Pulmonary Arterial Hypertension in Rats

Journal of Cardiovascular Pharmacology
Cardiovascular MedicinePharmacologyCardiology
2015English

Interleukin-10 Expression Mediated by an Adeno-Associated Virus Vector Prevents Monocrotaline-Induced Pulmonary Arterial Hypertension in Rats

Circulation Research
Cardiovascular MedicinePhysiologyCardiology
2007English

Mesenchymal Stem Cells Attenuates Vascular Remodelling in Pulmonary Hypertension Rats Induced by Monocrotaline

Heart
Cardiovascular MedicineCardiology
2012English

Interventions and Mechanisms of N‑acetylcysteine on Monocrotaline‑induced Pulmonary Arterial Hypertension

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2018English

Effects of Inorganic Nitrate in a Rat Model of Monocrotaline‐induced Pulmonary Arterial Hypertension

Basic and Clinical Pharmacology and Toxicology
MedicineToxicologyPharmacology
2019English

GPR143, a L-Dopa Receptor, Is Involved in Monocrotaline-Induced Pulmonary Hypertension in Rats

Proceedings for Annual Meeting of The Japanese Pharmacological Society
2020English

Metabolic Dysfunction in Pulmonary Arterial Hypertension

Current Hypertension Reports
Internal Medicine
2015English

The Metabolic Basis of Pulmonary Arterial Hypertension

Cell Metabolism
Cell BiologyMolecular BiologyPhysiology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy